| Line Item | 2025-09-27 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $533.8M | — | +58.4% |
| Gross Profit | $181.5M | — | +133.0% |
| R&D Expense | $81.4M | — | +9.6% |
| SG&A Expense | $85.1M | — | +11.5% |
| Operating Income | $6.7M | — | +108.1% |
| Income Tax | $1.0M | — | -68.8% |
| Net Income | $4.2M | — |
| Line Item | 2025-09-27 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $772.9M | +48.4% | +58.0% |
| Short-term Investments | $348.9M | -2.1% | -18.3% |
| Inventory | $531.6M | +13.1% | +31.8% |
| Current Assets | $2.09B | +21.4% | +27.5% |
| Total Assets | $4.61B | +9.3% | +16.2% |
| Current Liabilities |
| Line Item | 2025-09-27 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $57.9M | — | +46.2% |
| Capital Expenditures | $76.2M | — | +2.8% |
| Investing Cash Flow | -$67.8M | — | -43.9% |
| Financing Cash Flow | $262.1M | — | +336.8% |
| Free Cash Flow | -$18.3M | — | +47.0% |
| +105.1% |
| EPS (Basic) | $0.06 | — | +105.0% |
| EPS (Diluted) | $0.05 | — | +104.1% |
| $1.53B |
| +288.5% |
| +400.2% |
| Long-term Debt | $2.16B | -15.5% | -15.8% |
| Total Liabilities | $3.83B | +24.3% | +24.7% |
| Stockholders' Equity | $780.8M | -31.2% | -12.8% |